Sign In
Buy PCRX
$23.51
+0.80 (+3.52%)
At Close: Jun 23, 2026
RBC Capital Sticks to Its Buy Rating for Osmotica Pharmaceuticals (OSMT)
02:49pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Osmotica Pharmaceuticals (OSMT), with a price target of $10.00.
RBC Capital Sticks to Its Buy Rating for Osmotica Pharmaceuticals (OSMT)
02:49pm, Wednesday, 25'th Mar 2020
In a report released today,
Randall Stanicky
from RBC Capital reiterated a
Buy
rating on Osmotica Pharmaceuticals (
OSMT
–
Research Report
), with a price target of
$10.00
. The company’s shares c
RBC Capital Keeps a Buy Rating on Agile Therapeutics (AGRX)
02:47pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Agile Therapeutics (AGRX), with a price target of $8.00. The
